Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › desmopressin

desmopressin

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of desmopressin

9 trials tracked of desmopressin: 5 in phase 3 or 4 and 1 with published results. The most-cited published study has 17 citations.

9Trials tracked
5Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 5 Phase 2 2 Phase 1 1 Other / NA 1
  1. Phase 3 Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary Completed · 17 cited
  2. Phase 3 Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients Completed
  3. Phase 3 Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis Completed
  4. Phase 3 Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients Completed
  5. Phase 3 Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia Completed
  6. Phase 2 Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo Completed
Show 3 more trials
  1. Phase 2 A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults Completed
  2. Phase 1 A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers Completed
  3. N/A Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS) Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Lithium-associated nephrogenic diabetes insipidus may cause severe postoperative hypernatremia and polyuria
Nephrology Sys. Review
Lithium-associated nephrogenic diabetes insipidus may cause severe postoperative hypernatremia and polyuria Lithium use may cause kidney issues after surgery in patients
This case report describes a patient with schizophrenia and type 2 diabetes who developed severe hypernatremia and polyuria following a panc…
A man with schizophrenia and diabetes faced severe complications after surgery, highlighting how lithium can affect kidney function and flui…
Frontiers Aug 28, 2026
Intranasal desmopressin reduces bleeding risk in CKD patients during non-surgical procedures
Neurology Meta-analysis
Intranasal desmopressin reduces bleeding risk in CKD patients during non-surgical procedures Desmopressin may reduce bleeding for some kidney disease patients
This meta-analysis of 21 studies involving 7,944 participants evaluated peri-procedural desmopressin for bleeding in CKD patients. While the…
New data suggests that while desmopressin does not help all kidney patients, it may lower bleeding risks when given through the nose.
Frontiers Aug 27, 2026